FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

36514811000001101: Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Jan 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1737301000001110 Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1737321000001115 Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Is a Ertugliflozin 5mg tablets true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient Ertugliflozin L-pyroglutamic acid true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ertugliflozin true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Is a Steglatro true Inferred relationship Existential restriction modifier
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Has active ingredient Ertugliflozin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) 28 tablet 4 x 7 tablets Has AMP True Steglatro 5mg tablets (Merck Sharp & Dohme (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start